GridAI Technologies (GRDX) Accounts Payables (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Accounts Payables came in at $2.3 million in Q2 2026, down 30.46% on a YoY basis from $3.3 million in Q2 2025, and down 32.17% quarter-over-quarter from $3.4 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Accounts Payables (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Accounts Payables for 12 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Accounts Payables fell 30.46% year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.3 million (down 30.46% YoY), and the FY2025 full-year result was $3.4 million, up 14.27% from the prior year.
- Accounts Payables eased to $2.3 million in Q2 2026 per GRDX's latest filing, from $3.4 million in the prior quarter.
- Across five years, Accounts Payables topped out at $5.0 million in Q3 2025 and bottomed at $469760.0 in Q1 2023.
- Historically, Accounts Payables has averaged $2.4 million across 5 years, with a median of $2.3 million in 2026.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables plunged 86.38% in 2023, then jumped 433.89% in 2024.
- Over 5 years, Accounts Payables stood at $720040.0 in 2022, then declined by 23.02% to $554277.0 in 2023, then surged by 433.89% to $3.0 million in 2024, then rose by 14.27% to $3.4 million in 2025, then tumbled by 32.17% to $2.3 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $2.3 million, $3.4 million, and $5.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 25.08 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | 2.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Mn |
| Dec 31, 2025 | 3.38 Mn |
| Sep 30, 2025 | 4.97 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 2.85 Mn |
| Dec 31, 2024 | 2.96 Mn |
| Sep 30, 2024 | 2.21 Mn |
| Jun 30, 2024 | 2.01 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 554,277.00 |
| Sep 30, 2023 | 579,291.00 |
| Jun 30, 2023 | 1.59 Mn |
| Mar 31, 2023 | 469,760.00 |
| Dec 31, 2022 | 720,040.00 |
| Sep 30, 2022 | 3.58 Mn |
| Jun 30, 2022 | 3.97 Mn |
| Mar 31, 2022 | 3.45 Mn |
| Dec 31, 2021 | 2.71 Mn |
| Sep 30, 2021 | 18.58 Mn |
| Jun 30, 2021 | 4.64 Mn |